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SUMMARY
Endometriosis represents a common gynecological condition affecting 5%-15% of child-
bearing age women and up to 3%-5% of post-menopausal women. This disease is de-
fined by the presence of stromal and/or endometrial glandular epithelium implants in 
extra-uterine locations possibly compromising several sites. Humans and animals are 
daily exposed to chemical pollutants that could adversely influence physiological pro-
cesses and potentially cause diseases, including endometriosis. In this review, the authors 
aimed at settling the influence of environmental and dietary factors on endometriosis 
pathogenesis. The mechanism by which dioxin and its similes (TCDD/PCBs) act chang-
ing the endometrial physiology remains uncertain and is speculative due to the difficulty 
in assessing the exposure over intrauterine life, childhood and adulthood and its actual 
consequences, in addition to the limitations to its in vitro reproducibility. We need to 
better understand the mechanism of action of these environmental pollutants, not only 
on reproductive health, but also on overall health of individuals and so prevention strate-
gies, including not only population education, but setting exposure limits, less polluting 
techniques and a better use of our natural resources, could be promoted.
Keywords: Dioxins; aryl hydrocarbon receptor; tetrachlordibenzodioxin; endometrio-
sis; diet; food habits.
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INTRODUCTION
ENDOMETRIOSIS
Endometriosis represents a common gynecological con-
dition reaching 5%-15% of childbearing age women and 
up to 3%-5% of post-menopausal women1. The number of 
women with endometriosis is estimated to be seven mil-
lion in the USA2, being one of the main causes for gyneco-
logical hospitalization in industrialized countries3.
This disease is defined by the presence of stromal and/
or endometrial glandular epithelium implants in extra-
uterine location4, possibly compromising several sites, 
including ovaries, peritoneum, uterosacral ligaments, 
retrocervical area, rectovaginal septum, rectum/sigmoid, 
terminal ileum, vermiform appendix, urinary bladder, and 
ureters2,3,5-,7. Some patients with endometriosis are asymp-
tomatic; however, most of them have clinical complaints 
in different intensities, with the main ones being dysmen-
orrhea, chronic pelvic pain, infertility, deep dyspareunia, 
cyclic bowel and urinary symptoms, such as pain or bleed-
ing on defecation or urination during the menstrual pe-
riod. Among other factors, occasional nonspecificity of the 
clinical picture and the noncorrelation between symptoms 
and disease severity can explain the delay in endometriosis 
diagnosis2,5,8-11.
A number of aspects of the disease are still study tar-
gets, with the search of the etiopathogenesis standing out, 
considering that if the reason for the endometriosis focus 
development is understood, directing efforts to improve 
diagnosis and treatment will be possible12,13. Two main 
etiopathogenic hypothesis lines of thought have been cited 
for almost one century:
t coelomic metaplasia theory, where mesothelium 
turns into endometrial tissue14;
t retrograde menstruation theory, postulating the 
implant of endometrial cells from menstrual blood 
reflux through the Fallopian tubes into the abdo-
minal cavity15, occurring under the influence of a 
favorable hormone environment and immunologi-
cal factors which would not clear the cells out of the 
inappropriate site16,17.
Koninckx and Martin, in 199218, divided this disease 
into three distinct conditions: peritoneal, ovarian, and rec-
tovaginal septum endometriosis, with the last one being 
called deep infiltrating endometriosis. In the first case, pa-
tients with peritoneal implants would be included; in the 
second case, the well-known ovarian cysts, typical of the 
disease; and in the third case, the infiltrating endometrio-
sis affecting retrocervical and paracervical areas, in addi-
tion to gastrointestinal and genitourinary tracts.
Although the typical symptoms of endometriosis are 
well-known, they might be poorly specific or be related to 
the involvement sites of the disease foci12,13. Patients can 
experience pelvic pain, infertility, cyclic intestinal and/or 
urinary changes and this may not be an endometriosis 
case. Non-invasive endometriosis diagnosis via laboratory 
methods has no satisfactory results19-22, but despite defini-
tive diagnosis depends on surgical methods to obtain the 
material and disease histological confirmation, imaging 
methods have significantly progressed over last years, with 
high accuracy levels for deep endometriosis cases23-26.
Over the last years, much has been studied about the 
immunological factors in endometriosis pathogenesis and 
many abnormalities have been found16,27,28, with the main 
mechanism assessed being additional to the retrograde 
menstruation theory. For some reason that is uncertain at 
the moment, endometrial cells that enter the abdominal 
cavity would not be cleared and, thus, they would be al-
lowed to implant and the disease would be developed29.
The cells falling into endometrial cavity should be iden-
tified as antigens and undergo local immune response. 
Some cells, such as the macrophages, work as antigen-pre-
senting cells to T cells through the major histocompatibility 
complex (MHC). MHC can be class I or II; in the first case, 
it attracts cytotoxic T cells and, in the second case, helper 
T cells. Cytotoxic cells secrete lethal substances causing the 
target-cell death, whereas helper T cells secrete cytokines 
that can lead to cell death30. Changes in any of the above 
phases can be related to endometriosis genesis29.
EXPOSURE TO ENVIRONMENTAL FACTORS
Humans and animals are daily exposed to chemical pollut-
ants that can adversely influence physiological processes 
e potentially cause disease. Many of these environmental 
pollutants are persistent, having long half-lives and they 
can accumulate in the environment and even in living or-
ganisms and, thus, adversely influence gestational process, 
the children and the adult. A recent analysis by the Envi-
ronmental Working Group revealed the presence of 287 
different chemical agents in human umbilical cord and an 
important result: although not all children have been ex-
posed to all pollutants detected, no child was exposed to 
no pollutants31. It is difficult to determine the specific or 
combination effect of these numerous agents on the pro-
cess or disease development in specific organs, but many 
agents are known to be related to neoplasm development, 
immunological disorders, neuropsychomotor and repro-
ductive system function changes31.
Among numerous chemical agents identified in the hu-
man umbilical cord, 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) has been widely studied because it is considered 
the most toxic environmental pollutant ever produced by 
man32. However, certain polychlorinated biphenyls (PCBs) 
have a biologic toxicity similar to TCDD and, therefore, 
they can act by impairing reproductive function.
PCBs have been endocrine deregulating agents wide-
ly used as dieletric fluid in transformers, capacitors, and 
coolers since 1930. Although PCB production has been 
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banned in the United States in 1976, PCBs still persist in 
the air, water, and soil, and it has accumulated in fatty tis-
sue in fish, fowls, and mammals all over the world. As a re-
sult, human exposure to PCBs occurs mainly by consum-
ing animal products and dairy foods33.
The role of human exposure to PCBs in the develop-
ment of diseases related to hormones has been addressed 
in several epidemiological studies since early 1990. Most 
endometriosis studies focus on the dioxin form (coplanar 
PCBs inducing biological effects through an aromatic hy-
drocarbon receptor binding), but no association has been 
found33.
Whereas TCDD has been unwittingly introduced into 
our environment as a product resulting from industrial 
and incineration processes, PCBs have been widely ap-
plied and they were produced indiscriminately until they 
were banned worldwide in the 80s. These organochlorines 
are exceedingly resistant to degradation and, as they are 
lipophilic in nature, they accumulate and enhance in the 
food chain33,34.
In this review, we will try to explain the complexity and 
the challenges of determining the potential impact of ex-
posure to these agents with a focus on endometriosis.
REVIEW METHODS
A wide MEDLINE (1966-2010) and PubMed (1966-2010) 






Abstracts of all selected articles were read and the man-
uscripts were fully reviewed. References of all articles were 
reviewed in search of additional information. The article 
selection and their review were independently performed 
by two reviewers (PB and SP) for quality.
Three hundred and five articles were found and, out of 
these, we selected those published over the last 10 years, 
reaching 213 articles. Out of these, we tried to select those 
with a relevant sample and an appropriate review, meta-
analyses, and controlled studies, reaching a total of 44 
articles. The selected articles were as follows: 7 systematic 
reviews (Recommendation Grade A – level of evidence 
1A), 26 prospective and controlled studies (Recommenda-
tion Grade A – level of evidence 1B), 1 retrospective co-
hort (Recommendation Grade B – level of evidence 2B), 
1 case report (Recommendation Grade C – level of evi-
dence 4), 2 ecological studies (Recommendation Grade B 
– level of evidence 2C), and 7 simple reviews (Recommen-
dation Grade B – level of evidence 3A). Following, after 
an article reference review, we selected 6 additional studies 
performed more than 10 years ago, but relevant for our 
review, as they are pioneering studies.
PCBS AND ENDOMETRIOSIS
Although the accurate endometriosis etiology remains 
uncertain, the mechanism of retrograde menstruation15 
seems to be the most plausible hypothesis. However, as 
retrograde menstruation is a common event in women 
without endometriosis, some other mechanism, whether 
it is immunological or toxic, must act to allow endometrial 
cells to implant into the cavity. Because of the recognized 
ability of PCBs to change endometrial function either in 
animals or humans, it is not surprising the action of these 
pollutants on the disease etiopathogenesis was considered 
as related. However, as contamination might be found in 
food, it could be difficult to exclude other exposure sourc-
es from food or water even in a controlled study.
Although the hypothesis has been firstly reported al-
most 20 years ago35, studies trying to prove TCDD or PCB 
effect on the disease genesis are conflicting. Fasting prior 
to the collect for serum PCB measurement is known to 
produce false results and lactation is the main PCB excre-
tion route; however, few studies get a strict serum sample 
collect with serum lipid correction and taking into account 
breast feeding in the analyses36,37. In addition, different sta-
tistical analyses and different regions (urban/rural) stud-
ied could have contributed to discrepancies in the results.
Yet we will list the main effects assigned to PCBs/TCDD, 
making them possible contributors to endometriosis on-
set.
ENDOMETRIAL ACTION
PCBs/TCDD can bind to receptors (AhR), forming het-
erodimeric complexes binding to xenobiotic response ele-
ments and change the expression of genes influenced by 
these elements. AhR receptor is an activated ligand tran-
scription factor commonly reported as an orphan nuclear 
receptor, since the endogenous ligand is not known. In 
the non-bound form, AhR is present in the cytosol as a 
multiprotein complex associated with chaperon proteins. 
These receptors (AhR) are still known to be abundant in 
endometrium and immune system cells38. In an endome-
trial culture model39, even ephemeral endometrial tissue 
exposure to TCDD was observed to promote increased 
secretion of matrix metaloproteinases (MMPs), though in 
the presence of progesterone, which normally would sup-
press the expression of these enzymes.
Because of the powerful anti-inflammatory effect of 
progesterone, reduced sensitivity to this steroid could con-
tribute to the autoimmune nature of endometriosis, as well 
as to more specific local and systemic changes. However, 
only recently this loss of endometrial sensitivity to proges-
terone was recognized as a potential causal factor for endo-
metriosis. Over the menstrual cycle, as progesterone levels 
fall into the secretory phase, increased proinflammatory 
cytokines and chemokines and MMPs are seen, in prepara-
tion for the high inflammatory process of menstruation39,40.
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Furthermore, these PCBs/TCDD  +  AhR complexes 
can activate proinflammatory cytokine and chemokine 
genes, such as IL-1, IL-8, TNF-a, and RANTES, potential-
ly affording a chronic pattern of proinflammatory signal-
ing and bringing on cessation of the normal endometrial 
function. TCDD combination to 17b-estradiol is known to 
further potentiate the proinflammatory effect, raising the 
presence of RANTES and MIP-1a (macrophage protein 
1-alpha), entailing the ability to invade stromal endome-
trial cells and express MMP-2 and MMP-9 in them41.
DIETARY FACTORS
Today we know some diseases are certainly influenced 
by diet (insulin resistance, hypertension, gall bladder 
disease, celiac disease, etc.)42. Most recommendations by 
associations and societies related to endometriosis are 
known to be made based on case reports and personal 
experiences.
There are several plausible theories linking diet to 
endometriosis and dysmenorrhea. Prostaglandin release 
seems to be a pathogenic factor for both endometriosis 
and dysmenorrhea. Diet fatty acids are prostaglandin 
precursors. PGE2 and PGF2 are proinflammatory n6 fat-
ty acid metabolites, possibly increasing uterine contrac-
tion and painful symptoms. However, PGE3 and PGE3a 
are n3 fatty acid derivatives which are less potent in their 
inflammatory function; thus, they can reduce painful 
symptoms. N3 fatty acids are mainly found in marine 
oils, whereas n6 fatty acids are found in vegetable oils43.
Endometriosis is an estrogen-dependent disease. A re-
lationship between diet and other estrogen-dependent dis-
eases has already been shown44,45. Fiber intake can increase 
estrogen excretion46,47 and could, thus, play an inverse role 
in endometriosis risk; fat intake could reduce serum estro-
gen levels. A vegetarian diet would supposedly raise serum 
ligand and sex hormone carrier protein levels, thus reduc-
ing the available estrogen concentration48.
In a Cochrane review, Yap et al.49 could find vitamin B 
complex and magnesium intake, as well as omega 3 sup-
plements, can exert an anti-inflammatory role in patients 
with endometriosis. Omega 3 and 6 fatty acids were pro-
posed as possibilities to improve pain symptoms related 
to endometriosis by modulating the biosynthesis and 
prostaglandin biochemical activity related to pelvic pain. 
Likewise, magnesium and vitamins B are related to anti-
inflammatory prostaglandins production and miometrial 
relaxation. Moreover, diet based on vegetables, vitamins, 
omega 3 and magnesium ultimately reduces animal pro-
tein intake and therefore reduces the excess of body fat 
and estrogen peripheral production50.
However, up to this point, there is not sufficient evi-
dence from controlled studies so that appropriate conclu-
sions can be drawn whether or not using diets as preven-
tive or adjuvant factors in endometriosis treatment.
CONCLUSION
The mechanism by which dioxin and its similes 
(TCDD/PCBs) act on endometrial physiology changes re-
mains uncertain and speculative because it is difficult to 
assess the exposure in intrauterine life, in childhood and 
adulthood, as well as its real consequences, in addition to 
the limitations of its in vitro reproduction. In order to ob-
serve and determine the possible role of any environmen-
tal pollutants, a number of groups has performed in vitro 
and in vivo techniques aiming to find the cell mechanisms 
of the disease onset.
Studies assessing the time and degree of exposure, age 
group and exposure to concomitant factors should be con-
ducted to determine how all of these factors could contrib-
ute to endometriosis genesis. 
Ultimately, we should better understand the mecha-
nism of action of these environmental pollutants not only 
on reproductive health, but also on the general health of 
the individual to promote prevention strategies which 
should include not only population education, but estab-
lishing limits of exposure, less polluting techniques and a 
better use of our natural resources.
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